TABLE 2.

Results of group statistics on cognitive performance differences between patient groups and controls

	HC (n = 26)		PAT (n = 17)						LH PAT (n = 12)		RH PAT (n = 10)
DV	M	SE	M	SE	F	p a	ES	CI	M	SE	M	SE	ES	CI
VLMT_∑Dg1‐5	59	1.43	47	1.78	28.47	<.001	−1.30	[−1.97 to –0.63]	42	3.31	44	4.81	−0.58	[−1.44–0.28]
VLMT_Dg5‐Dg7	1	0.31	3	0.39	12.78	<.05	0.98	[.34–1.63]	4	0.48	2	0.50	4.01	[2.56–5.46]
ANT_RT/Nr	1.9	0.05	2.1	0.06	5.92	<.05	0.29	[−.33–0.90]	1.9	0.03	2.4	0.27	−16.03	[−20.84 to −11.22]
TMT_RTexe	22	2.58	39	3.20	18.67	<.001	1.17	[0.51–1.83]	42	4.72	33	9.30	1.83	[0.84–2.83]

Note: DV = dependent variable, HC = healthy controls, PAT = glioma patients, LH = left‐hemispheric, RH = right‐hemispheric, n = number of included subjects, M = mean, SE = standard error, F = value of test statistic, p = significance, ES = effect size, CI = confidence interval, VLMT = Verbal Learning and Memory Test, ANT = Attention Network Test, TMT = Trail‐Making‐Test, VLMT_∑Dg1‐5 = sum of recalled words, VLMT_Dg5‐Dg7 = number of words forgotten, ANT_RT/Nr = quotient of reaction time and correct trials, TMT_RTexe = difference in reaction time in seconds between TMT‐A and TMT‐B.

^aSignificant results (p < .05, two‐tailed), ES and CI are printed in bold.